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Abstract
Introduction: Diabetic Nephropathy (DN) is the single 
most common cause of end stage renal disease (ESRD) 
in many countries. Inflammation is a potential factor in 
the development and progression of DN and recent data 
indicate that diabetes includes an inflammatory component 
which may contribute to diabetic complications.
Methods: This study was conducted at Ain Shams 
University Hospital on 95 patients with type-2 diabetes 
mellitus complicated with retinopathy and fifteen age- 
and sex-matched healthy volunteers. Diabetic patients 
were divided into 4 groups according to the degree of 
proteinuria. Serum tumor necrosis factor-α (TNF-α), 
urine TNF-α and C-reactive protein (CRP) levels were 
measured in all subjects. Correlations between these 
inflammatory parameters and degree of proteinuria, 
duration of diabetes and degree of glycemic control were 
examined. 
Results: Levels of the three inflammatory parameters were 
significantly higher in diabetic patients when compared 
to control subjects, and they were positively correlated 
to urinary protein excretion. There was significant 
positive correlation between serum and urine TNF-α and 
duration of diabetes, as well as between serum TNF-α 
and glycemic control. Serum and urine TNF-α remained 
as independent predictors of urine protein excretion in 
diabetic patients with overt proteinuria after forward 
stepwise multiple regression analysis.
Conclusion: Serum and urine TNF-α and CRP levels are 
significantly elevated in this group of diabetic patients, 
and correlate positively with severity of proteinuria. This 
suggests a significant role for TNF-α in the pathogenesis 
and progression of renal injury in diabetes mellitus.
Keywards: Diabetic nephropathy; Proteinuria; Tumor 
necrosis factor-α
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Introduction
Diabetic Nephropathy (DN) is the single most common 
cause of end stage renal disease (ESRD) in many 
countries. It accounts for more than 20% of the cases of 
chronic renal failure [1]. The pathogenic mechanisms 
and molecular events involved in the development 
and progression of DN are not completely known. 
Traditionally, the development of renal lesions in patients 
with type 2 diabetes mellitus is attributed to  interactions 
of metabolic and hemodynamic factors.  Inflammation 
is a potential factor in the development and progression 
of DN, and recent data indicate that an inflammatory 
component contributes to the development of  diabetic 
complications [2-6]. 
Tumor Necrosis Factor alpha (TNF-α) is a 157 
amino-acid peptide produced mainly by monocytes, 
macrophages, B and T lymphocytes as well as glomerular 
mesangial cells. Elevated TNF-α level in urine is found 
and accused to play a role in some immune mediated 
glomerulonephritidis (e.g. IgA nephropathy and Anti-
Glomerular Basement Membrane Disease) [7]. The role 
of TNF-α in mediating renal and glomerular lesions was 
not elucidated until 1989, when Bertani and associates 
observed that the infusion of human recombinant TNF-α 
into rabbits induced the presence of inflammatory cells in 
the glomerular capillaries, with the prominent findings of 
glomerular endothelial damage, polymorphonuclear cell 
accumulation and fibrin deposition within the capillary 
lumen [8]. Since then, diverse studies have demonstrated 
that this cytokine, through a broad series of bioactivities, 
may promote significant actions in the kidney with the 
development of renal injury [9]. 
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The local actions and implications of intra-renal TNF-α 
are  interesting. In 1991, Hasegawa et al reported that 
macrophages incubated with glomerular basement 
membranes from diabetic rats produced greater 
amounts of TNF-α than did macrophages incubated 
with membranes from non-diabetic animals [10]. 
These authors suggested for the first time the potential 
implication of this cytokine in the pathogenesis of 
DN. Furthermore, TNF-α is a potential causative agent 
implicated in glomerular and tubulointerstitial damage 
in the setting of diabetes [11]. Also, a recent study 
by Moriwaki et al found  that TNF-α inhibition is a 
potential therapeutic strategy in experimental diabetic 
rats [12]. It is important to note that this cytokine may 
be produced in the diabetic kidney by infiltrating cells 
(mainly macrophages) as well as intrinsically by renal 
cells (endothelial, mesangial, glomerular and tubular 
epithelial cells) [4]. Within the glomerulus, TNF-α 
displays a number of effects that are relevant to the 
manifestations observed at the initial stages and during the 
progression of glomerular injury. TNF-α is implicated in 
the misbalance between vasodilator and vasoconstrictor 
mediators, which may result in alterations of glomerular 
blood flow and glomerular filtration rate. Additionally, 
this cytokine is cytotoxic to glomerular, mesangial and 
epithelial cells, and may induce direct renal damage. Also 
TNF-α is able to promote the local generation of reactive 
oxygen species, which affects the barrier function of the 
glomerular capillary wall resulting in enhanced albumin 
permeability, independently of hemodynamic factors 
or effects of recruited inflammatory cells. Regarding 
tubulointerstitial damage, exposure of tubular epithelial 
cells to TNF-α increased the synthesis and secretion 
of lymphocyte and neutrophil chemoattractant factors 
as well as the cell surface expression of intercellular 
adhesion molecule-1, which has been implicated in the 
development of renal injury in diabetes. Finally, TNF-α 
has stimulatory effects on sodium uptake by proximal 
tubule cells, contributing to sodium retention and renal 
hypertrophy, typical alterations that occur during the 
early stage of DN [3].
Methods
This cross-sectional study was conducted on 95 type-2 
diabetic patients with retinopathy and 15 healthy control 
subjects. Diabetic patients with retinopathy were divided 
into 4 groups: Group-I included twenty diabetic patients 
with microalbuminuria and estimated GFR >90, group-2 
included thirty patients with overt albuminuria and 
estimated GFR >90, group-III included thirty patients 
with overt albuminuria and estimated GFR <30, and 
group-IV included fifteen diabetic patients without 
albuminuria and with estimated GFR >90.
To avoid potential confounding factors, we excluded 
patients with current acute illness (including infections), 
current cigarette smoking, immunologic or malignant 
diseases, morbid cardiovascular illness, medical history 
of clinical cardiovascular events (cardiac, cerebral or 
peripheral vascular disease) in the last 6 months, and 
patients on angiotensin converting enzyme inhibitors 
(ACEi), angiotensin receptor antagonists or non-
steroidal anti-inflammatory drugs (NSAIDs). Before 
inclusion, the possible existence of active immunological 
diseases, malignancy or infections was investigated if 
suspected. White blood cell count was lower than  10000/
mm3 in all cases. Tumor markers including carcino-
embryonic antigen, α-fetoprotein, cancer antigen-125 
and prostate-specific antigen were negative in screened 
subjects. Serological tests for antinuclear antibodies, 
antineutrophilic cytoplasmic antibodies, cryoglobulins, 
rheumatoid factor and complement factors C3 and 
C4 were negative or within the normal range. Urine 
cultures and serology for hepatitis B and C and human 
immunodeficiency virus were also negative. 
All subjects gave informed consent to participate in the 
study. Relevant clinical history and examination were 
recorded. The presence of diabetic nephropathy was an 
inclusion criterion for all diabetic patients in the study. 
Arterial blood pressure was measured using mercury 
sphygmomanometer with the patient in the sitting 
position after 5 minutes of rest. Three readings separated 
by 2 minutes were taken and the average was used for 
calculation. Mean arterial blood pressure [diastolic blood 
pressure + 1/3(systolic blood pressure – diastolic blood 
pressure)] and Body Mass Index (BMI) were recorded. The 
glomerular filtration rate was estimated by Modification 
of Diet in Renal Disease Abbreviated Equation (MDRD): 
[GFR = 186 × (serum Cr)-1.154 × (age)-0.203 × (0.742 if 
female) × (1.210 if African American)]. Glycemic control 
was assessed by glycosylated hemoglobin (HbA1c). 
Proteinuria was measured by albumin dipsticks, urinary 
microalbumin kits and protein/creatinine (Pr/Cr) 
ratio in morning urine sample. Pelvic and abdominal 
ultrasonographic examination was done for all subjects. 
Blood and urine samples for the estimation of serum 
and urine TNF-α  were drawn from each subject in the 
morning (between 8 and 11 am). Blood samples were 
collected in sterile tubes, centrifuged and the supernatant 
stored with urine samples at -70°C until assayed by 
immunoenzymetric assay for the in-vitro quantitative 
measurement of human TNF-α using BioSource TNF-α 
EASIA Kit. Estimation of serum high sensitivity 
C-reactive protein (hs-CRP) was done for all subjects by 
enzyme-linked immunosorbent assay (ELISA).
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Correlation between serum and urine TNF-α and serum 
CRP was done with the duration of diabetes, mean 
arterial blood pressure, HbA1c, degree of proteinuria, 
as well as estimated GFR. Data were analyzed using 
Statistical Package for Social Sciences (SPSS) software 
computer program version 15. Mean ± standard deviation 
and frequencies were used to describe quantitative 
and qualitative data respectively. Independent Student 
t-test was used for comparison of quantitative variables 
between groups. One-way ANOVA test was used for 
comparison of quantitative variables among more than 
two independent groups. Chi-square test was used 
for comparison of distribution of qualitative variables 
among different groups. Correlation between continuous 
variables was performed using Pearson correlation 
coefficient. P value ≤ 0.05 was considered significant.
Forward stepwise multiple regression analysis was 
performed to determine the independent association 
between relevant patient characteristics and clinical 
parameters as potential predictor variables (age, gender, 
duration of diabetes, BMI, MABP, HbA1C, serum 
TNF-α, urine TNF-α, hs-CRP) and estimated GFR and 
Pr/Cr ratio as the dependant variable.
Results
Baseline characteristics of the studied groups are shown 
(Table 1). Levels of serum TNF-α, urine TNF-α and 
hs-CRP were significantly different between study groups 
(Figures 1-2). Serum TNF-α levels were significantly 
and positively correlated to the duration of diabetes and 
HbA1C levels. Urine TNF-α levels were significantly 
and positively correlated to the duration of diabetes but 
not to HbA1C levels. 
Scatter blots revealed a positive correlation between 
serum TNF-α, urine TNF-α, hs-CRP and Pr/Cr ratio 
(Figures 3-5). After forward stepwise multiple regression 
analysis, serum TNF-α and urine TNF-α remained 
as independent predictors of Pr/Cr among patients in 
group-II (R2 = 0.46 and 0.32 respectively, P<0.05) and 
group-III (R2 = 0.36 and 0.31 respectively, P<0.05). 
Discussion
Diabetic nephropathy (DN) is the principal cause of 
ESRD  in the Western world, with renal disease as a 
major cause of morbidity and mortality in the diabetic 
population. It has been estimated that type 2 diabetes 
now contributes to at least 50% of patients who have 
diabetes in end-stage renal failure programs [3]. There 
is growing evidence that activated innate immunity and 
inflammation are relevant factors in the pathogenesis 
of diabetes; with convincing data that type-2 diabetes 
includes an inflammatory component [5]. Regarding 
diabetic complications, experimental and clinical 
studies have demonstrated that DN exhibits signs of 
inflammation, with proinflammatory cytokines being 
suggested as important factors in the development of 
renal injury [6]. Several studies have reported that serum 
levels of inflammatory markers are greater in patients 
with diabetes with increased urinary albumin excretion 
(UAE) with respect to normoalbuminuric subjects. Also 
there was a significant relationship between serum TNF-α 
level and urinary protein excretion in patients with type-2 
Table 1:  Comparison between all groups as regards studied variables
Control   
(mean ± SD) 









Duration of diabetes (years) 8.9 ± 2.8 13.9 ± 3.8 18.1 ± 4.5 7.9 ± 2.6 0.00
MABP (mmHg) 89.7 ± 4.1 100.6 ± 11.8 105 ± 14.3 106.6 ± 11.7 100.2 ± 9.8 0.00
BMI 29.2 ± 3.6 28.4 ± 4.8 27.8 ± 3.3 29.3 ± 4.2 29.3 ± 4.4 0.58
eGFR (ml/min/1.73m²) - 102 ± 10.1 102.1 ± 10.7 19.7 ± 13.4 103 ± 14 -
Hb A1C - 8.1 ± 1.1 7.4 ± 1.4 7.7 ± 1.4 7.3 ± 1.1 0.24
Pr/Cr - - 2.11 ± 1.44 2.26 ± 1.39 0.07 ± 0.04 0.00
Serum TNF-α (pg/ml) 36.3 ± 6.7 478.5 ± 117.1 686.7 ± 177.6 467 ± 293 244.3 ± 93.7 0.00
Urine TNF-α (pg/mg) 33.3 ± 11.9 420.8 ± 141.5 570 ± 126.4 472.7 ± 247.3 225 ± 79.46 0.00
hs-CRP (mg/l) 0.6 ± 0.4 4.4 ± 1.1 7.2 ± 1.6 6.2 ± 2.4 2.9 ± 1.2 0.00
MABP: mean arterial blood pressure; BMI: body mass index; eGFR: estimated glomerular filteration rate; HbA1C: glycated hemoglobin C; Pr/Cr: 
protein creatinine ratio; serum TNF-α: serum tumour necrosis factor alpha; urine TNF-α: urine tumour necrosis factor alpha; hs-CRP; high sensitivity 
C-reactive protein
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diabetes with overt nephropathy and renal insufficiency 
[3]. Studies on animal models of DN have shown that 
renal expression of TNF-α is increased compared to 
kidneys of non-diabetic animals [13]. Preliminary 
clinical reports have found a significant relationship 
between the urinary excretion of this cytokine and UAE 
in type-2 diabetic patients. Also serum TNF-α has been 
reported to be elevated in diabetic subjects, and even in 
patients with only impaired glucose tolerance, compared 
to healthy individuals [11]. However, clinical studies 
analyzing the serum and urinary excretion of TNF-α in 
diabetic patients in relation to proteinuria are scarce. 
Our study highlights the possible role of TNF-α in the 
development and progression of renal injury in diabetic 
patients, and demonstrates that serum and urinary 
concentrations of this cytokine are enhanced in diabetic 
subjects, increasing as renal damage progresses. The 
availability of highly sensitive assays resulted in that 
hs-CRP has become an exquisite marker of chronic 
subclinical inflammation. In our study, hs-CRP levels in 
type-2 diabetic patients with microalbuminuria and overt 
proteinuria were significantly greater than in diabetic 
patients without albuminurea and healthy individuals. 
Furthermore, there was a positive correlation between 
serum and urine TNF-α and hs-CRP level and urinary 
protein excretion. These results are in agreement with 
the results of Navarro et al, who compared 65 type-2 
diabetic patients and 21 healthy controls and found that 
serum and urine TNF-α and hs-CRP were significantly 
higher in diabetic than in control subjects [3]. We also 
observed that the mean values of serum and urine TNF-α 
and hs-CRP are higher in diabetics with proteinuria than 
those without albuminuria. The results of Moriwaki et al 
support our findings, as he observed that serum TNF-α 
levels in diabetic patients with microalbuminuria were 
significantly increased as compared to those without 
albuminuria [14]. We also observed that levels of 
these inflammatory cytokines were higher in diabetics 
with macroalbuminuria compared to those with 
microalbuminuria. This suggests that levels of serum 
and urine TNF-α and  hs-CRP increase when proteinuria 
increases and nephropathy progresses. These results are 
in agreement with those of Navarro et al, who observed 
significant differences in serum and urine TNF-α and 
hs-CRP levels between patients with microalbuminuria 
and patients with macroalbuminuria, being higher among 
patients with macroalbuminuria [11]. 
We found significant association between serum, but not 
urinary, TNF–α and HbA1C level. The reverse was found 
in the studies of Navarro et al, who attributed their findings 
to the relation between metabolic control and kidney 
production of this cytokine [3,11]. This is conceivable, 
but metabolic control could also affect the severity 
of the disease and its progression and hence systemic 
production of this cytokine, which could explain the 
correlation between metabolic control and serum TNF-α 
in our results. The observations of Chen et al support 
our finding, as he observed that serum TNF-α level was 
related to glycemic control (HbA1C). They proposed that 
hyperglycemia can induce elevated serum TNF-α levels 
through oxidative stress pathway [15]. Further studies are 
required to confirm these associations. The relationship 
between serum TNF-α and BMI is a matter of debate. 
Figure 1: Comparison of serumTNF-α and urine TNF-α between study groups (P=0.00)
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Some authors showed no relation between the two while 
others did. In a study conducted by Lele et al on 35 
diabetic subjects and 50 healthy controls, no association 
was found between serum TNF-α and BMI [16]. On 
the contrary, Navarro et al found significant correlation 
between serum TNF-α and BMI [11]. They explained 
that serum levels of TNF-α are essentially determined by 
the systemic production of this adipocytokine by adipose 
tissue, unrelated to metabolic factors such as HbA1C. 
This difference in results could be attributed to the fact 
that Lele et al conducted his study on Asian Indians. He 
reported that Asian Indians have unique biochemical and 
hormone features which may be considered as additional 
features to the so called ‘Asian Indian Phenotype’ [16]. 
Our results  concur with those of of Lele et al, as we 
found no significant association between serum TNF-α 
and BMI. This may also have resulted from genetic and 
racial differences. 
Our results showed that serum and urine TNF-α were 
independently and significantly associated with Pr/Cr 
in Group-II and Group-III.  These results are supported 
by those of Navarro et al who also found that serum 
and urine TNF-α were independent of and significantly 
associated with UAE [11].
Conclusion
Serum and urine TNF-α and hs-CRP levels are elevated 
in  type-2 diabetic patients and their levels correlate with 
markers of glomerular damage. This suggests a significant 
role for TNF-α in the pathogenesis and progression of 
renal injury in diabetes mellitus.
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